Sintilimab+Bevacizumab+TACE vs. Lenvatinib+TACE for Advanced HCC | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Sintilimab+Bevacizumab+TACE vs. Lenvatinib+TACE for Advanced HCC	Hepatocellular Carcinoma Non-resectable	Recruiting	Phase 3	2023-08-14		NCT05985798

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Cancer Hospital & Institute of Guangzhou Medical University	33
Affiliated Hospital of Guangdong Medical University	27
First People's Hospital of Foshan	44
Lecong Hospital, Shunde District, Foshan	1
Second Affiliated Hospital of Guangzhou Medical University	70
Zhongshan People's Hospital, Guangdong, China	46

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The second Affiliated Hospital of Guangzhou Medical University	Guangzhou	China	26